Guangzhou Shijing Medical Software Co., Ltd., founded in 2008, is a medical technology company dedicated to innovative R&D in ophthalmology and optometry. With a deep focus on artificial intelligence, image analysis, and virtual reality, Shijing Medical is committed to becoming a leader in full-lifecycle functional eye disease solutions.
Core Products & Clinical Impact
Shijing Medical offers two primary digital therapeutic solutions:
-
DOBOSO – Digital diagnosis and treatment solution for visual function training
-
BaBy Blissful – PBM (photobiomodulation) digital therapeutic solution
These products are widely used in over 3,000 ophthalmic hospitals and optometry centers across China, as well as in home therapy settings. With more than 500,000 cumulative users, they have received consistent praise from clinicians, parents, and patients. The company maintains a leading market share among similar products.
Innovation & Intellectual Property
Shijing Medical has strategically positioned 200+ intellectual property assets, including over 60 granted invention patents. The company continuously invests in cutting-edge technologies such as AI, image analysis, and VR, and has been awarded provincial-level key R&D projects. Additionally, Shijing collaborates with numerous renowned medical institutions on clinical trials and research initiatives, making significant contributions to advancing ophthalmic care.
Industry Leadership & Standards
Shijing Medical has led or participated in developing multiple industry standards, including the Technical and Application Specifications for VR Visual Training Systems. The company has also co-published major industry research reports with Frost & Sullivan and MedSci, such as:
-
2026 Blue Book on the Current Status and Future Trends of Children and Adolescent Myopia Management
-
Blue Book on the Current Status of Digital Treatment for Pediatric Amblyopia and Strabismus in China
-
White Paper on the Current Status of Digital Treatment for Pediatric Amblyopia and Strabismus in China
These publications reflect Shijing's commitment to driving healthy development in the vision care industry.
Awards & Recognition
Shijing Medical has been honored with numerous prestigious accolades:
-
Listed among Guangzhou's "Top 100 High-Growth Potential Pre-IPO High-Tech Enterprises"
-
Selected for Deloitte's "China Rising Star" list
-
Ranked among China's "Top 10 Digital Therapy Companies"
-
Winner of the "Global Ophthalmic Clinical Application Award"
-
Recognized as "China's Leading Brand in Visual Function Training"
Why Choose Shijing Medical?
-
Proven Clinical Efficacy: Trusted by 3,000+ hospitals and 500,000+ users
-
Strong IP Portfolio: 200+ patents, including 60+ invention patents
-
Cutting-Edge Technology: AI, VR, and image analysis integration
-
Industry Influence: Lead author of multiple standards and blue papers
-
Award-Winning Innovation: Recognized by industry and financial authorities
Conclusion
Guangzhou Shijing Medical Software Co., Ltd. is not just a technology developer—it is a trusted partner in vision health, delivering evidence-based digital therapeutics that improve patient outcomes and drive the future of ophthalmic care.
Learn more at the official website: www.shijingmed.com
www.shijingmed.com
Guangzhou Shijing Medical Software Co., Ltd.
About Author
